DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Eiermann W, Pienkowski T, Crown J. et al.
Phase III study of doxorubicin/cyclophosphamide with concomitant versus sequential docetaxel as adjuvant treatment in patients with human epidermal growth factor receptor 2-normal, node-positive breast cancer: BCIRG-005 trial.
J Clin Oncol 2011;
29: 3877-3884
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.